Evidence map›Paper›PMID 42783892›Full record

ArticleMarine drugs2026

Resolution-Phase Immunometabolic Reprogramming by

Amal D Premarathna, Katarzyna M Dziubinska-Kuehn, Muthupandian Saravanan, Anti Sooäär, Indrek Reile, Tamer A E Ahmed, Maxwell T Hincke, Rando Tuvikene

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amal D PremarathnaSchool of Natural Sciences and Health, Tallinn University, Narva mnt 29, 10120 Tallinn, Estonia.ORCID 0000-0002-9748-398X
Katarzyna M Dziubinska-KuehnNational Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia.ORCID 0000-0002-4526-841X
Muthupandian SaravananPrince Fahad bin Sultan Chair for Biomedical Research, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0000-0002-1480-3555
Anti SooäärSchool of Natural Sciences and Health, Tallinn University, Narva mnt 29, 10120 Tallinn, Estonia.
Indrek ReileNational Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia.ORCID 0000-0003-3278-7947
Tamer A E AhmedDepartment of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.ORCID 0000-0002-6922-6193
Maxwell T HinckeDepartment of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Rando TuvikeneSchool of Natural Sciences and Health, Tallinn University, Narva mnt 29, 10120 Tallinn, Estonia.ORCID 0000-0002-5542-3030

Funding

Estonian Research Council PRG1808Estonian Research Council Taristu24-TK15Natural Sciences and Engineering Research Council of Canada RGPIN-2022-04803
6 · The paper itself

Abstract

Sulfated polysaccharides from red seaweeds are emerging as versatile bioactive macromolecules. Here, we report that funoran-type galactans from

Indexed as

Anti-Inflammatory AgentsInflammationMacrophagesPolysaccharidesRhodophytaAnimalsCarrageenanEdemaMaleMicePhagocytosisRAW 264.7 CellsAnti-Inflammatory AgentsCarrageenanPolysaccharidesanti-inflammatoryfunoranGelidiopsis variabilisimmunometabolic reprogrammingmacrophage polarizationresolution-phase inflammation

Identifiers

PMID42783892
PMCPMC13608200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.